[go: up one dir, main page]

NO863636D0 - Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater. - Google Patents

Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater.

Info

Publication number
NO863636D0
NO863636D0 NO863636A NO863636A NO863636D0 NO 863636 D0 NO863636 D0 NO 863636D0 NO 863636 A NO863636 A NO 863636A NO 863636 A NO863636 A NO 863636A NO 863636 D0 NO863636 D0 NO 863636D0
Authority
NO
Norway
Prior art keywords
weight
acid derivatives
preparations
resorable
transdermal
Prior art date
Application number
NO863636A
Other languages
English (en)
Other versions
NO172028C (no
NO863636L (no
NO172028B (no
Inventor
Manfred Loehner
Hans Heinrich Wagener
Original Assignee
Dolorgiet Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolorgiet Gmbh & Co Kg filed Critical Dolorgiet Gmbh & Co Kg
Publication of NO863636D0 publication Critical patent/NO863636D0/no
Publication of NO863636L publication Critical patent/NO863636L/no
Publication of NO172028B publication Critical patent/NO172028B/no
Publication of NO172028C publication Critical patent/NO172028C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO863636A 1985-09-12 1986-09-11 Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrer NO172028C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853532562 DE3532562A1 (de) 1985-09-12 1985-09-12 Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben

Publications (4)

Publication Number Publication Date
NO863636D0 true NO863636D0 (no) 1986-09-11
NO863636L NO863636L (no) 1987-03-13
NO172028B NO172028B (no) 1993-02-22
NO172028C NO172028C (no) 1993-06-02

Family

ID=6280783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863636A NO172028C (no) 1985-09-12 1986-09-11 Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrer

Country Status (10)

Country Link
US (1) US4849418A (no)
EP (1) EP0215423B1 (no)
JP (1) JPH078786B2 (no)
AT (1) ATE63220T1 (no)
CA (1) CA1269328A (no)
DE (2) DE3532562A1 (no)
ES (1) ES2002140A6 (no)
NO (1) NO172028C (no)
YU (1) YU46012B (no)
ZA (1) ZA866917B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE69302677T2 (de) * 1992-02-12 1996-10-02 Janssen Cilag S P A Liposomale piroxycam formulierung
EP0625898B1 (en) * 1992-02-12 1996-05-15 JANSSEN-CILAG S.p.A. Liposomal piroxicam formulations
JPH07503953A (ja) * 1992-02-12 1995-04-27 ジヤンセン・シラグ・ソチエタ・ペル・アチオニ リポソームイトラコナゾール組成物
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
WO2000032179A2 (en) 1998-12-01 2000-06-08 University Of Kentucky Research Foundation Use of nicotonic acid derivatives for the treatment of dna damage in skin cells
JP2003509350A (ja) * 1999-09-11 2003-03-11 ザ、プロクター、エンド、ギャンブル、カンパニー 注加可能な液体賦形剤
DE10001096A1 (de) * 2000-01-13 2001-07-26 Lohmann Therapie Syst Lts TTS mit Reservoirschicht zur Aufnahme und Abgabe von Duftstoffen
US7138133B2 (en) * 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
US20040258716A1 (en) * 2002-06-17 2004-12-23 Shen Gao Ibuprofen suspension
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
DK1982696T3 (da) * 2007-04-19 2010-07-26 August Wolff Gmbh & Co Kg Arzn Gel til behandling af sår
GB0921686D0 (en) * 2009-12-11 2010-01-27 Reckitt Benckiser Healthcare I Topical formulation
CA2835062C (en) 2011-05-03 2019-08-13 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
NZ606177A (en) * 2012-01-30 2014-03-28 Dolorgiet Gmbh & Co Kg Compositions for the treatment of actinic keratosis
EP3213744A1 (de) * 2016-03-01 2017-09-06 Chemische Fabrik Kreussler & Co. Gmbh Galenische zubereitung von nsaid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
DE1617480B2 (de) * 1967-08-01 1973-02-01 Farbwerke Hoechst AG, vormals Mei ster Lucius & Brunmg, 6000 Frankfurt Gelgrundlagen
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
US4511563A (en) * 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
JPS6127920A (ja) * 1984-07-16 1986-02-07 Akiyoshi Masataka 消炎鎮痛性外用医薬組成物
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln

Also Published As

Publication number Publication date
YU126186A (en) 1989-10-31
NO172028C (no) 1993-06-02
EP0215423B1 (de) 1991-05-08
ZA866917B (en) 1987-05-27
ES2002140A6 (es) 1988-07-16
NO863636L (no) 1987-03-13
DE3532562A1 (de) 1987-03-12
CA1269328A (en) 1990-05-22
JPH078786B2 (ja) 1995-02-01
NO172028B (no) 1993-02-22
ATE63220T1 (de) 1991-05-15
EP0215423A2 (de) 1987-03-25
YU46012B (sh) 1992-12-21
EP0215423A3 (en) 1988-03-23
US4849418A (en) 1989-07-18
DE3679128D1 (de) 1991-06-13
JPS6261917A (ja) 1987-03-18

Similar Documents

Publication Publication Date Title
NO863636D0 (no) Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
EE9400356A (et) Polüetüleenglükool proteiin konjugaadid, ühendid, nende kasutamine, meetod konjugaatide valmistamiseks ja ravimvormid
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
NO893270D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
WO1994022441A3 (en) Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
FI910112A0 (fi) Preparat foer lokalt bruk.
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
MY101266A (en) Pharmaceutical formulations
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
SE8700829L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
MK1K Patent expired